Skip to main content
Top
Published in: World Journal of Surgery 8/2020

01-08-2020 | Liver Cirrhosis | Original Scientific Report

Use of Direct Liver Stiffness Measurement in Evaluating the Severity of Liver Cirrhosis in Patients with Hepatocellular Carcinoma

Authors: Jin Gu, Erlei Zhang, Binyong Liang, Zunyi Zhang, Xin Long, Shuai Xiang, Wenqiang Wang, Xiaoping Chen, Zhiyong Huang

Published in: World Journal of Surgery | Issue 8/2020

Login to get access

Abstract

Background

Severity of liver cirrhosis plays an important role in determining the safe extents of hepatectomy in patients with hepatocellular carcinoma (HCC). The aim of this study was to investigate whether direct liver stiffness measurement can help surgeons to evaluate the severity of liver cirrhosis in HCC patients.

Methods

Overall, 119 HCC patients who underwent open hepatectomy were retrospectively studied. The severity of liver cirrhosis was histologically staged using the Laennec staging system. Direct liver stiffness measurement was performed during operation using a sclerometer device named LX-C Shaw hardmeter, and its efficacy in assessing the severity of liver cirrhosis was compared with that of transient elastography (TE) and cirrhotic severity scoring (CSS) previously proposed by our team.

Results

Liver stiffness measured by LX-C Shaw hardmeter was significantly correlated with the severity of liver cirrhosis. Spearman correlation coefficients for the correlation between the severity of liver cirrhosis and direct liver stiffness measurement, TE, and CSS were 0.751, 0.454, and 0.705, respectively (all P < 0.001). The areas under the receiver operating characteristic curves (AUCs) of direct liver stiffness measurement were 0.891 for moderate cirrhosis and 0.944 for severe cirrhosis and superior to those of TE (0.735 and 0.776, respectively) and CSS (0.888 and 0.905, respectively).

Conclusions

Direct liver stiffness measurement is a useful method in evaluating the severity of liver cirrhosis in HCC patients.
Literature
1.
go back to reference Akinyemiju T, Abera S, Ahmed M et al (2017) The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global burden of disease study 2015. JAMA Oncol 3:1683–1691CrossRef Akinyemiju T, Abera S, Ahmed M et al (2017) The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global burden of disease study 2015. JAMA Oncol 3:1683–1691CrossRef
2.
go back to reference Chen XP, Wu ZD, Huang ZY et al (2005) Use of hepatectomy and splenectomy to treat hepatocellular carcinoma with cirrhotic hypersplenism. Br J Surg 92:334–339CrossRef Chen XP, Wu ZD, Huang ZY et al (2005) Use of hepatectomy and splenectomy to treat hepatocellular carcinoma with cirrhotic hypersplenism. Br J Surg 92:334–339CrossRef
3.
go back to reference Zhou SJ, Zhang EL, Liang BY et al (2016) Morphologic severity of cirrhosis determines the extent of liver resection in patients with hepatocellular carcinoma and Child–Pugh grade A cirrhosis. J Surg Res 200:444–451CrossRef Zhou SJ, Zhang EL, Liang BY et al (2016) Morphologic severity of cirrhosis determines the extent of liver resection in patients with hepatocellular carcinoma and Child–Pugh grade A cirrhosis. J Surg Res 200:444–451CrossRef
4.
go back to reference Kim SU, Jung KS, Lee S et al (2014) Histological subclassification of cirrhosis can predict recurrence after curative resection of hepatocellular carcinoma. Liver Int 34:1008–1017CrossRef Kim SU, Jung KS, Lee S et al (2014) Histological subclassification of cirrhosis can predict recurrence after curative resection of hepatocellular carcinoma. Liver Int 34:1008–1017CrossRef
5.
go back to reference Huang ZY, Liang BY, Xiong M et al (2016) Severity of cirrhosis should determine the operative modality for patients with early hepatocellular carcinoma and compensated liver function. Surgery 159:621–631CrossRef Huang ZY, Liang BY, Xiong M et al (2016) Severity of cirrhosis should determine the operative modality for patients with early hepatocellular carcinoma and compensated liver function. Surgery 159:621–631CrossRef
6.
go back to reference Kutami R, Nakashima Y, Nakashima O et al (2000) Pathomorphologic study on the mechanism of fatty change in small hepatocellular carcinoma of humans. J Hepatol 33:282–289CrossRef Kutami R, Nakashima Y, Nakashima O et al (2000) Pathomorphologic study on the mechanism of fatty change in small hepatocellular carcinoma of humans. J Hepatol 33:282–289CrossRef
7.
go back to reference Regev A, Berho M, Jeffers LJ et al (2002) Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 97:2614–2618CrossRef Regev A, Berho M, Jeffers LJ et al (2002) Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 97:2614–2618CrossRef
8.
go back to reference Rousselet MC, Michalak S, Dupre F et al (2005) Sources of variability in histological scoring of chronic viral hepatitis. Hepatology 41:257–264CrossRef Rousselet MC, Michalak S, Dupre F et al (2005) Sources of variability in histological scoring of chronic viral hepatitis. Hepatology 41:257–264CrossRef
9.
go back to reference Huang ZY, Chen G, Hao XY et al (2011) Outcomes of non-anatomic liver resection for hepatocellular carcinoma in the patients with liver cirrhosis and analysis of prognostic factors. Langenbecks Arch Surg 396:193–199CrossRef Huang ZY, Chen G, Hao XY et al (2011) Outcomes of non-anatomic liver resection for hepatocellular carcinoma in the patients with liver cirrhosis and analysis of prognostic factors. Langenbecks Arch Surg 396:193–199CrossRef
10.
go back to reference Ziol M, Handra-Luca A, Kettaneh A et al (2005) Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 41:48–54CrossRef Ziol M, Handra-Luca A, Kettaneh A et al (2005) Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 41:48–54CrossRef
11.
go back to reference Sporea I, Sirli R, Deleanu A et al (2010) Liver stiffness measurements in patients with HBV vs HCV chronic hepatitis: a comparative study. World J Gastroenterol 16:4832–4837CrossRef Sporea I, Sirli R, Deleanu A et al (2010) Liver stiffness measurements in patients with HBV vs HCV chronic hepatitis: a comparative study. World J Gastroenterol 16:4832–4837CrossRef
12.
go back to reference Ogawa E, Furusyo N, Toyoda K et al (2007) Transient elastography for patients with chronic hepatitis B and C virus infection: non-invasive, quantitative assessment of liver fibrosis. Hepatol Res 37:1002–1010CrossRef Ogawa E, Furusyo N, Toyoda K et al (2007) Transient elastography for patients with chronic hepatitis B and C virus infection: non-invasive, quantitative assessment of liver fibrosis. Hepatol Res 37:1002–1010CrossRef
13.
go back to reference Saito H, Tada S, Nakamoto N et al (2004) Efficacy of non-invasive elastometry on staging of hepatic fibrosis. Hepatol Res 29:97–103CrossRef Saito H, Tada S, Nakamoto N et al (2004) Efficacy of non-invasive elastometry on staging of hepatic fibrosis. Hepatol Res 29:97–103CrossRef
14.
go back to reference Zhang EL, Zhang ZY, Wang SP et al (2016) Predicting the severity of liver cirrhosis through clinical parameters. J Surg Res 204:274–281CrossRef Zhang EL, Zhang ZY, Wang SP et al (2016) Predicting the severity of liver cirrhosis through clinical parameters. J Surg Res 204:274–281CrossRef
15.
go back to reference Sandrin L, Fourquet B, Hasquenoph JM et al (2003) Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 29:1705–1713CrossRef Sandrin L, Fourquet B, Hasquenoph JM et al (2003) Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 29:1705–1713CrossRef
16.
go back to reference Kim MY, Cho MY, Baik SK et al (2011) Histological subclassification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertension. J Hepatol 55:1004–1009CrossRef Kim MY, Cho MY, Baik SK et al (2011) Histological subclassification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertension. J Hepatol 55:1004–1009CrossRef
17.
go back to reference DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845CrossRef DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845CrossRef
18.
go back to reference Fluss R, Faraggi D, Reiser B (2005) Estimation of the Youden Index and its associated cutoff point. Biom J 47:458–472CrossRef Fluss R, Faraggi D, Reiser B (2005) Estimation of the Youden Index and its associated cutoff point. Biom J 47:458–472CrossRef
19.
go back to reference Castera L, Vergniol J, Foucher J et al (2005) Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128:343–350CrossRef Castera L, Vergniol J, Foucher J et al (2005) Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128:343–350CrossRef
20.
go back to reference Kim BK, Oh HJ, Park JY et al (2013) Early on-treatment change in liver stiffness predicts development of liver-related events in chronic hepatitis B patients receiving antiviral therapy. Liver Int 33:180–189CrossRef Kim BK, Oh HJ, Park JY et al (2013) Early on-treatment change in liver stiffness predicts development of liver-related events in chronic hepatitis B patients receiving antiviral therapy. Liver Int 33:180–189CrossRef
21.
go back to reference Foucher J, Castera L, Bernard PH et al (2006) Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations. Eur J Gastroenterol Hepatol 18:411–412CrossRef Foucher J, Castera L, Bernard PH et al (2006) Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations. Eur J Gastroenterol Hepatol 18:411–412CrossRef
22.
go back to reference Kettaneh A, Marcellin P, Douvin C et al (2007) Features associated with success rate and performance of FibroScan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients. J Hepatol 46:628–634CrossRef Kettaneh A, Marcellin P, Douvin C et al (2007) Features associated with success rate and performance of FibroScan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients. J Hepatol 46:628–634CrossRef
23.
go back to reference Chong CC, Wong GL, Chan AW et al (2017) Liver stiffness measurement predicts high-grade post-hepatectomy liver failure: A prospective cohort study. J Gastroenterol Hepatol 32:506–514CrossRef Chong CC, Wong GL, Chan AW et al (2017) Liver stiffness measurement predicts high-grade post-hepatectomy liver failure: A prospective cohort study. J Gastroenterol Hepatol 32:506–514CrossRef
24.
go back to reference Millonig G, Reimann FM, Friedrich S et al (2008) Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis. Hepatology 48:1718–1723CrossRef Millonig G, Reimann FM, Friedrich S et al (2008) Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis. Hepatology 48:1718–1723CrossRef
25.
go back to reference Coco B, Oliveri F, Maina AM et al (2007) Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat 14:360–369CrossRef Coco B, Oliveri F, Maina AM et al (2007) Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat 14:360–369CrossRef
Metadata
Title
Use of Direct Liver Stiffness Measurement in Evaluating the Severity of Liver Cirrhosis in Patients with Hepatocellular Carcinoma
Authors
Jin Gu
Erlei Zhang
Binyong Liang
Zunyi Zhang
Xin Long
Shuai Xiang
Wenqiang Wang
Xiaoping Chen
Zhiyong Huang
Publication date
01-08-2020
Publisher
Springer International Publishing
Published in
World Journal of Surgery / Issue 8/2020
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-020-05528-9

Other articles of this Issue 8/2020

World Journal of Surgery 8/2020 Go to the issue